Amirifar P, Ranjouri MR, Lavin M, Abolhassani H, Yazdani R, Aghamohammadi A. Ataxia-telangiectasia: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management. Expert Rev Clin Immunol. 2020;16(9):859–71.
Article CAS PubMed Google Scholar
Natale VAI, Cole TJ, Rothblum-Oviatt C, Wright J, Crawford TO, et al. Growth in ataxia telangiectasia. Orphanet J Rare Dis. 2021;16(1):123.
Article PubMed PubMed Central Google Scholar
Stray-Pedersen A, Jónsson T, Heiberg A, Lindman CR, Widing E, Aaberge IS, et al. The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents. Clin Exp Immunol. 2004;137(1):179–86.
Article CAS PubMed PubMed Central Google Scholar
Ambrose M, Gatti RA. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood. 2013;121(20):4036–45.
Article CAS PubMed PubMed Central Google Scholar
Paulino TL, Rafael MN, Hix S, Shigueoka DC, Ajzen SA, Kochi C, et al. Is age a risk factor for liver disease and metabolic alterations in ataxia telangiectasia patients? Orphanet J Rare Dis. 2017;12(1):136.
Article PubMed PubMed Central Google Scholar
Lavin MF, Lederman HM. Chromosomal breakage syndromes associated with immunodeficiency. In: Stiehm ER, Ochs HD, Winkelstein JA, editors. Immunologic disorders in infants & children. 5th ed. Philadelphia: Elsevier/Saunders; 2004. p. 580–7.
Guo Z, Deshpande R, Paull TT. ATM activation in the presence of oxidative stress. Cell Cycle. 2010;9(24):4805–11.
Article CAS PubMed PubMed Central Google Scholar
Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair Amst. 2002;1(1):3–25.
Article CAS PubMed Google Scholar
Donath H, Woelke S, Theis M, Heß U, Knop V, Herrmann E, et al. Progressive liver disease in patients with ataxia telangiectasia. Front Pediatr. 2019;7:458.
Article PubMed PubMed Central Google Scholar
Weiss B, Krauthammer A, Soudack M, Lahad A, Sarouk I, Somech R, et al. Liver disease in pediatric patients with ataxia telangiectasia: a novel report. J Pediatr Gastroenterol Nutr. 2016;62(4):550–5.
Article CAS PubMed Google Scholar
Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 2004;144(4):505–11.
van Os NJH, Jansen AFM, van Deuren M, Haraldsson A, van Driel NTM, Etzioni A, et al. Ataxia-telangiectasia: Immunodeficiency and survival. Clin Immunol. 2017;178:45–55.
Szczawińska-Popłonyk A, Ossowska L, Jończyk-Potoczna K. Granulomatous liver disease in ataxia-telangiectasia with the hyper-igm phenotype: a case report. Front Pediatr. 2020;8:570330.
Article PubMed PubMed Central Google Scholar
Caballero T, Caba-Molina M, Salmerón J, Gómez-Morales M. Nonalcoholic steatohepatitis in a patient with ataxia-telangiectasia. Case Reports Hepatol. 2014;2014:761250.
Article PubMed PubMed Central Google Scholar
Patil MM, Patil SV. Ataxia telangiectasia with hepatocellular carcinoma. Indian Pediatr. 2009;46(6):546.
Krishna Kumar G, Al Saadi A, Yang SS, McCaughey RS. Ataxia-telangiectasia and hepatocellular carcinoma. Am J Med Sci. 1979;278:157–60.
Article CAS PubMed Google Scholar
Yoshitomi F, Zaitsu Y, Tanaka K. Ataxia-telangiectasia with renal cell carcinoma and hepatoma. Virchows Arch A Pathol Anat Histol. 1980;389(1):119–25.
Article CAS PubMed Google Scholar
Weinstein S, Scottolini AG, Loo SY, Caldwell PC, Bhagavan NV. Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred. Arch Pathol Lab Med. 1985;109(11):1000–4.
Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344(7):495–500.
Article CAS PubMed Google Scholar
Dhingra S, Ward SC, Thung SN. Liver pathology of hepatitis C, beyond grading and staging of the disease. World J Gastroenterol. 2016;22(4):1357–66.
Article CAS PubMed PubMed Central Google Scholar
European Association for the Study of the Liver; List of panel members (alphabetical order), Berzigotti A, Boursier J, Castera L, Cazzagon N, Friedrich-Rust M, Petta S, Thiele M, Tsochatzis E. Easl clinical practice guidelines (Cpgs) on non-invasive tests for evaluation of liver disease severity and prognosis- 2020 update. J Hepatol. 2021;S0168–8278(21):00398–406.
Tsai E, Lee TP. Diagnosis and evaluation of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, including noninvasive biomarkers and transient elastography. Clin Liver Dis. 2018;1:73–92.
Wong VW, Adams LA, de Lédinghen V, Wong GL, Sookoian S. Noninvasive biomarkers in NAFLD and NASH-current progress and future promise. Nat Rev Gastroenterol Hepatol. 2018;8:461–78.
Biberci Keskin E, Coban G. Evaluation of liver biopsy findings and comparison with noninvasive fibrosis scores in patients with non-alcoholic steatohepatitis. Medeni Med J. 2019;34(4):354–9.
PubMed PubMed Central Google Scholar
McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59(9):1265–9.
Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, ESID registry working party and collaborators, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763–70.
World Health Organization. Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1–452.
Frisancho AR. Anthropometric standards for the assessment of growth and nutritional status. Ann Arbor: The University of Michigan Press; 1990. p. 189.
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660–7.
Article PubMed PubMed Central Google Scholar
Lohman TG. Advances in body composition assessment: current issues in exercises science. Illinois: Human Kinetic Publisher; 1992. p. 335.
Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol. 1988;60(709):23.
Deurenberg P, Pieters JJ, Hautuast JG. The assessment of the body fat percentage by skinfold thickness measurement in childhood e young adolescent. Br J Nutr. 1990;63:293–303.
Article CAS PubMed Google Scholar
Blackburn GL, Thornton PA. Nutritional assessment of the hospitalized patients. Med Clin North Am. 1979;63:11103–15.
Article CAS PubMed Google Scholar
Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–86.
Article CAS PubMed Google Scholar
Khoury M, Manlhiot C, McCrindle BW. Role of the waist/height ratio in the cardiometabolic risk assessment of children classified by body mass index. J Am Coll Cardiol. 2013;62(8):742–51.
Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls and boys. Arch Dis Child. 1969;44:291–303.
Article CAS PubMed PubMed Central Google Scholar
Maggi FA, Braga-Neto P, Chien HF, Gama MTD, Rezende Filho FM, Saraiva-Pereira ML, et al. Cross-cultural adaptation and validation of the international cooperative ataxia rating scale (ICARS) to Brazilian Portuguese. Arq Neuropsiquiatr. 2018;76(10):674–84.
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–26.
Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–54.
Article CAS PubMed Google Scholar
Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57(10):1441–7.
留言 (0)